Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Background: The optimal anti-angiogenic strategy as second-line treatment in RAS wild-type metastatic colorectal cancer (mCRC) treated with anti-EGFR (Epidermal Growth Factor Receptor) based first-line treatment is still debated. Methods: This multicenter, real-world, retrospective study is aimed at...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Parisi, Alessandro, Cortellini, Alessio, Cannita, Katia, Venditti, Olga, Camarda, Floriana, Calegari, Maria Alessandra, Salvatore, Lisa, Tortora, Giampaolo, Rossini, Daniele, Germani, Marco Maria, Boccaccino, Alessandra, Dell’Aquila, Emanuela, Fulgenzi, Claudia, Santini, Daniele, De Tursi, Michele, Tinari, Nicola, Di Marino, Pietro, Lombardi, Pasquale, Roselló Keränen, Susana, Huerta Álvaro, Marisol, Zurlo, Ina Valeria, Corsi, Domenico Cristiano, Emiliani, Alessandra, Zanaletti, Nicoletta, Troiani, Teresa, Vitale, Pasquale, Giampieri, Riccardo, Merloni, Filippo, Occhipinti, Mario Alberto, Marchetti, Paolo, Roberto, Michela, Mazzuca, Federica, Ghidini, Michele, Indini, Alice, Garajova, Ingrid, Zoratto, Federica, Delle Monache, Simona, Porzio, Giampiero, Ficorella, Corrado
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281759/
https://ncbi.nlm.nih.gov/pubmed/32429380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051259
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk